NCT06461767

Brief Summary

Compared with the patients with episodic migraine those with chronic migraine have worst quality of life and more severe headache related disability we investigate Repetitive transcranial magnetic stimulation in treatment and prophylaxis of chronic migraine

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 11, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 17, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

June 18, 2024

Status Verified

June 1, 2024

Enrollment Period

1 year

First QC Date

June 11, 2024

Last Update Submit

June 14, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • improvement of headache severity and number of attacks of headache before and after intervention by visual analogue scale and headache impact test

    improvement of headache severity and number of attacks of headache before and after intervention by visual analogue scale and headache impact test

    one month after treatment

Study Arms (4)

group (1) will rTMS over left motor cortex

ACTIVE COMPARATOR

Repetitive transcranial magnetic stimulation parameters: stimulation site: left motor cortex intensity: 70% of resting motor threshold frequency: 15 Hz number of pulses: 30 number of trains: 40

Device: transcranial magnetic stimulation device

group (2) will receive rTMS over left dorsolateral prefrontal cortex

ACTIVE COMPARATOR

Repetitive transcranial magnetic stimulation parameters: stimulation site: left dorsolateral prefrontal cortex intensity: 70% of resting motor threshold frequency: 15 Hz number of pulses: 30 number of trains: 40

Device: transcranial magnetic stimulation device

group (3) will receive rTMS over left dorsolateral prefrontal cortex and left motor cortex

ACTIVE COMPARATOR

Repetitive transcranial magnetic stimulation parameters: stimulation site: left dorsolateral prefrontal cortex and left motor cortex intensity: 70% of resting motor threshold frequency: 15 Hz number of pulses: 30 number of trains: 40

Device: transcranial magnetic stimulation device

group (4) will receive sham stimulation

SHAM COMPARATOR

Repetitive transcranial magnetic stimulation parameters: stimulation site: the coil will be perpendicular over vertex of skull intensity: 70% of resting motor threshold frequency: 15 Hz number of pulses: 30 number of trains: 40

Device: transcranial magnetic stimulation device

Interventions

Repetitive transcranial magnetic stimulation parameters: stimulation site: left dorsolateral prefrontal cortex and left motor cortex intensity: 70% of resting motor threshold frequency: 15 Hz number of pulses: 30

group (1) will rTMS over left motor cortexgroup (2) will receive rTMS over left dorsolateral prefrontal cortexgroup (3) will receive rTMS over left dorsolateral prefrontal cortex and left motor cortexgroup (4) will receive sham stimulation

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • A study sample of patients with chronic migraine according to international classification of headache disorders-3 (ICHD-3).
  • Patients are regular on follow up visits.

You may not qualify if:

  • Patients with depression by Hamiliton scale of depression by using its Arabic version Translated by Dr Lotfy Fateem
  • patients on prophylactic medications for chronic migraine.
  • pregnancy.
  • cochlear implants, cardiac pacemaker, and metal body implanted in head-and-neck region.
  • Patients refused to give informed consent.
  • History of seizures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag faculty of medicine

Sohag, 02, Egypt

RECRUITING

Study Officials

  • Tarek Mohamed

    Sohag faculty of medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: the patient will divide into 4 groups first group will receive stimulation over the left motor cortex second group will receive stimulation over left dorsolateral prefrontal cortex third group will receive stimulation over both left motor cortex and left dorsolateral prefrontal cortex fourth group will receive sham stimulation
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

June 11, 2024

First Posted

June 17, 2024

Study Start

January 1, 2024

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

June 18, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, CSR

Locations